Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

Clinical trial NCT02480374 · COMPLETED

Trial details

NCT number: NCT02480374
Sponsor: Imunon
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2015-09-01
Primary completion: 2017-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.